Pituitary gland volume and psychosocial stress among children at elevated risk for schizophrenia

Psychological Medicine

Volumn 45, Issue 15, 2015, Pages 3281-3292

  Cullen, A E ^a   Day, F L ^a   Roberts, R E ^a   Pariante, C M ^a   Laurens, K R ^a,b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Schizophrenia Research Institute   (Australia)

Author keywords

Childhood trauma; diathesis stress model; genetic high risk; hypothalamic pituitary adrenal axis; psychosis vulnerability

Indexed keywords

CHILD; ETIOLOGY; FEMALE; GENETIC PREDISPOSITION; HUMAN; HYPOPHYSIS; LIFE EVENT; MALE; MENTAL STRESS; PATHOLOGY; PUNISHMENT; RISK; SCHIZOPHRENIA;

CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE CHANGE EVENTS; MALE; PITUITARY GLAND; PUNISHMENT; RISK; SCHIZOPHRENIA; STRESS, PSYCHOLOGICAL;

EID: 84944277700     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291715001282     Document Type: Article

References (50)

1. Afifi TO, Mota NP, Dasiewicz P, MacMillan HL, Sareen J (2012). Physical punishment and mental disorders: results from a nationally representative US sample. Pediatrics 130, 184-192.
2. Borges S, Gayer-Anderson C, Mondelli V (2013). A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis. Psychoneuroendocrinology 38, 603-611.
3. Bradley AJ, Dinan TG (2010). A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. Journal of Psychopharmacology 24, 91-118.
4. Büschlen J, Berger GE, Borgwardt SJ, Aston J, Gschwandtner U, Pflueger MO, Kuster P, Radu EW, Stieglitz RD, Riecher-Rossler A (2011). Pituitary volume increase during emerging psychosis. Schizophrenia Research 125, 41-48.
5. Carskadon MA, Acebo C (1993). A self-administered rating scale for pubertal development. Journal of Adolescent Health 14, 190-195.
6. Chong RY, Uhart M, McCaul ME, Johnson E, Wand GS (2008). Whites have a more robust hypothalamic-pituitary-adrenal axis response to a psychological stressor than blacks. Psychoneuroendocrinology 33, 246-254.
7. Collip D, Nicolson NA, Lardinois M, Lataster T, van Os J, Myin-Germeys I (2011). Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychological Medicine 41, 2305-2315.
8. Cullen AE, Fisher HL, Roberts RE, Pariante CM, Laurens KR (2014a). Daily stressors and negative life events in children at elevated risk of developing schizophrenia. British Journal of Psychiatry 204, 354-360.
9. Cullen AE, Zunszain PA, Dickson H, Roberts RE, Fisher HL, Pariante CM, Laurens KR (2014b). Cortisol awakening response and diurnal cortisol among children at elevated risk for schizophrenia: relationship to psychosocial stress and cognition. Psychoneuroendocrinology 46, 1-13.
10. Fisher HL, Caspi A, Poulton R, Meier MH, Houts R, Harrington H, Arseneault L, Moffitt TE (2013). Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychological Medicine 43, 2077-2086.
11. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkotter J, McGuire P, Yung A (2013). The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 70, 107-120.
12. Garner B, Chanen AM, Phillips L, Velakoulis D, Wood SJ, Jackson HJ, Pantelis C, McGorry PD (2007). Pituitary volume in teenagers with first-presentation borderline personality disorder. Psychiatry Research: Neuroimaging 156, 257-261.
13. Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B, Brewer WJ, Smith DJ, Dazzan P, Berger GE, Yung AR, van den Buuse M, Murray R, McGorry PD, Pantelis C (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry 58, 417-423.
14. Goodman R (2001). Psychometric properties of the strengths and difficulties questionnaire. Journal of the American Academy of Child and Adolescent Psychiatry 40, 1337-1345.
15. Habets P, Collip D, Myin-Germeys I, Gronenschild E, van Bronswijk S, Hofman P, Lataster T, Lardinois M, Nicolson NA, van Os J, Marcelis M (2012). Pituitary volume, stress reactivity and genetic risk for psychotic disorder. Psychological Medicine 42, 1523-1533.
16. Heubeck B, O'Sullivan C (1998). An exploration into the nature, frequency and impact of school hassles in the middle school years. Australian Psychologist 33, 130-137.
17. Klomp A, Koolschijn PC, Hulshoff Pol HE, Kahn RS, Haren NE (2012). Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. International Journal of Neuropsychopharmacology 15, 281-288.
18. Laurens KR, Hobbs MJ, Sutherland M, Green MJ, Mould GL (2012). Psychotic-like experiences in a community sample of 8, 000 children aged 9-11 years: an item response theory analysis. Psychological Medicine 47, 1495-1506.
19. Laurens KR, Hodgins S, Maughan B, Murray RM, Rutter ML, Taylor EA (2007). Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years. Schizophrenia Research 90, 130-146.
20. Laurens KR, Hodgins S, Taylor E, Murray RM (2011). Is earlier intervention for schizophrenia possible?: Identifying antecedents of schizophrenia in children aged 9-12 years. In Schizophrenia: The Final Frontier (ed. A. S. David, P. McGuffin and S. Kapur), pp. 19-32. Psychology Press: London.
21. Lipsey MW, Wilson DB (2001). Practical Meta-Analysis. Sage Publications: Thousand Oaks, CA.
22. MacMaster FP, El-Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M (2007). Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophrenia Research 92, 207-210.
23. Marsman R, Nederhof E, Rosmalen JG, Oldehinkel AJ, Ormel J, Buitelaar JK (2012). Family environment is associated with HPA-axis activity in adolescents. The TRAILS study. Biological Psychology 89, 460-466.
24. Maxwell ME (1992). Family Interview for Genetic Studies. National Institute of Mental Health: St Louis, MO.
25. Mittal VA, Dhruv S, Tessner KD, Walder DJ, Walker EF (2007). The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol. Biological Psychiatry 61, 1179-1186.
26. Mondelli V, Dazzan P, Gabilondo A, Tournikioti K, Walshe M, Marshall N, Schulze KK, Murray RM, McDonald C, Pariante CM (2008). Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 33, 1004-1012.
27. Nicolo JP, Berger GE, Garner BA, Velakoulis D, Markulev C, Kerr M, McGorry PD, Proffitt TM, McConchie M, Pantelis C, Wood SJ (2010). The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study. Schizophrenia Research 116, 49-54.
28. Office for National Statistics (2010). Neighbourhood Statistics by Local Authority. National Statistics. http://www. neighbourhood.statistics.gov.uk/dissemination/
29. Pariante CM (2008). Pituitary volume in psychosis: the first review of the evidence. Journal of Psychopharmacology 22, 76-81.
30. Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C, Fearon P, Orr K, Hutchinson G, Pantelis C, Velakoulis D, Jones PB, Leff J, Murray RM (2005). Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30, 1923-1931.
31. Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ, Brewer W, Smith DJ, Dazzan P, Yung AR, Zervas IM, Christodoulou GN, Murray R, McGorry PD, Pantelis C (2004). Pituitary volume in psychosis. British Journal of Psychiatry 185, 5-10.
32. Romo-Nava F, Hoogenboom WS, Pelavin PE, Alvarado JL, Bobrow LH, Macmaster FP, Keshavan M, McCarley RW, Shenton ME (2013). Pituitary volume in schizophrenia spectrum disorders. Schizophrenia Research 146, 301-307.
33. Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC (2001). Decreased pituitary volume in patients with bipolar disorder. Biological Psychiatry 50, 271-280.
34. Shah JL, Malla AK (2015). Much ado about much: stress, dynamic biomarkers and HPA axis dysregulation along the trajectory to psychosis. Schizophrenia Research 162, 253-260.
35. Shah JL, Tandon N, Howard ER, Mermon D, Miewald JM, Montrose DM, Keshavan MS (2015). Pituitary volume and clinical trajectory in young relatives at risk for schizophrenia. Psychological Medicine. Published online: 7 July 2015. doi:10.1017/S003329171500077X.
36. Shelton KK, Frick PJ, Wootton JM (1996). Assessment of parenting practices in families of elementary school-age children. Journal of Clinical Child Psychology 25, 317-329.
37. Sugranyes G, Thompson JL, Corcoran CM (2012). HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis. Journal of Psychiatric Research 46, 1389-1393.
38. Takahashi T, Nakamura K, Nishiyama S, Furuichi A, Ikeda E, Kido M, Nakamura Y, Kawasaki Y, Noguchi K, Seto H, Suzuki M (2013).Increased pituitary volumeinsubjectsatrisk for psychosis and patients with first-episode schizophrenia. Psychiatry and Clinical Neurosciences 67, 540-548.
39. Takahashi T, Suzuki M, Velakoulis D, Lorenzetti V, Soulsby B, Zhou SY, Nakamura K, Seto H, Kurachi M, Pantelis C (2009). Increased pituitary volume in schizophrenia spectrum disorders. Schizophrenia Research 108, 114-121.
40. Takahashi T, Zhou SY, Nakamura K, Tanino R, Furuichi A, Kido M, Kawasaki Y, Noguchi K, Seto H, Kurachi M, Suzuki M (2011). Longitudinal volume changes of the pituitary gland in patients with schizotypal disorder and first-episode schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35, 177-183.
41. Thomas LA, De Bellis MD (2004). Pituitary volumes in pediatric maltreatment-related posttraumatic stress disorder. Biological Psychiatry 55, 752-758.
42. Upadhyaya AR, El-Sheikh R, MacMaster FP, Diwadkar VA, Keshavan MS (2007). Pituitary volume in neuroleptic-naive schizophrenia: a structural MRI study. Schizophrenia Research 90, 266-273.
43. Walker E, Mittal V, Tessner K (2008). Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annual Review of Clinical Psychology 4, 189-216.
44. Walker EF, Diforio D (1997). Schizophrenia: a neural diathesis-stress model. Psychological Review 104, 667-685.
45. Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, McGlashan TH, Woods SW (2013). Cortisol levels and risk for psychosis: initial findings from the North American Prodrome Longitudinal Study. Biological Psychiatry 74, 410-417.
46. Walker EF, Walder DJ, Reynolds F (2001). Developmental changes in cortisol secretion in normal and at-risk youth. Development and Psychopathology 13, 721-732.
47. Walter A, Studerus E, Smieskova R, Tamagni C, Rapp C, Borgwardt SJ, Riecher-Rossler A (2015). Pituitary gland volume in at-risk mental state for psychosis: a longitudinal MRI analysis. CNS Spectrums 20, 122-129.
48. Wechsler D (1999). Wechsler Abbreviated Scale of Intelligence (WASI) Manual. Psychological Corporation: San Antonio, TX.
49. Wilke M, Holland SK, Altaye M, Gaser C (2008). Template-O-Matic: a toolbox for creating customized pediatric templates. Neuroimage 41, 903-913.
50. Zammit S, Kounali D, Cannon M, David AS, Gunnell D, Heron J, Jones PB, Lewis S, Sullivan S, Wolke D, Lewis G (2013). Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. American Journal of Psychiatry 170, 742-750.